Incyte to Present at Upcoming Investor Conference
WILMINGTON, Del.–(BUSINESS WIRE)–
Incyte (Nasdaq:INCY) announced today that it will present at the 39th Annual J. P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 7:30 a.m. EST.
The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 90 days.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201209005032/en/
Incyte Contacts
Media
Catalina Loveman
+1 302 498 6171
[email protected]
Investors
Michael Booth, DPhil
+1 302 498 5914
[email protected]
Christine Chiou
+1 302 274 4773
[email protected]
KEYWORDS: United States North America Delaware
INDUSTRY KEYWORDS: Managed Care Banking Research Other Health General Health Professional Services Pharmaceutical Science Other Professional Services Biotechnology Finance Health Other Science
MEDIA:
Logo |
![]() |